title: Harmonizing standards for producing clinical-grade therapies from pluripotent stem cells.
authors.affiliation: 1] Centre for Stem Cell Biology, Department of Biomedical Science, University of Sheffield Western Bank, Sheffield, UK. [2] Coordinator of the International Stem Cell Initiative.
authors.forename: Peter W
authors.initials: PW
authors.lastname: Andrews
authors.forename: Joy
authors.initials: J
authors.lastname: Cavagnaro
authors.affiliation: Access BIO, Boyce, Virginia, USA.
authors.forename: Joy
authors.initials: J
authors.lastname: Cavanagro
authors.affiliation: Alliance for Regenerative Medicine/Athersys, Cleveland, Ohio, USA.
authors.forename: Robert
authors.initials: R
authors.lastname: Deans
authors.forename: Ellen
authors.initials: E
authors.lastname: Feigal
authors.affiliation: California Institute for Regenerative Medicine, San Francisco, California, USA.
authors.forename: Ellen
authors.initials: E
authors.lastname: Feigel
authors.affiliation: International Society for Cell Therapy, Vancouver, BC, Canada.
authors.forename: Ed
authors.initials: E
authors.lastname: Horowitz
authors.affiliation: American Society of Hematology, University of Toronto and Princess Margaret Cancer Centre, Toronto, ON, Canada.
authors.forename: Armand
authors.initials: A
authors.lastname: Keating
authors.affiliation: 1] National Institutes of Health Center for Regenerative Medicine, Bethesda, Maryland, USA. [2] New York Stem Cell Foundation, New York, New York, USA.
authors.forename: Mahendra
authors.initials: M
authors.lastname: Rao
authors.affiliation: Scottish National Blood Transfusion Service Headquarters, Edinburgh, UK.
authors.forename: Marc
authors.initials: M
authors.lastname: Turner
authors.affiliation: Scottish Center for Regenerative Medicine, University of Edinburgh, Edinburgh BioQuarter, Edinburgh, UK.
authors.forename: Ian
authors.initials: I
authors.lastname: Wilmut
authors.affiliation: 1] Kyoto Center for iPS Cell Research and Application, Kyoto University, Shogoin, Sakyo-ku, Kyoto, Japan. [2] International Society for Stem Cell Research at the time of submission and acceptance of this work.
authors.forename: Shinya
authors.initials: S
authors.lastname: Yamanaka
mesh_terms: D001709:Biotechnology; D064987:Cell- and Tissue-Based Therapy / Q000592:standards*; D006801:Humans; D039904:Pluripotent Stem Cells / Q000166:cytology*
references.citation: Regen Med. 2010 Jul;5(4):569-79
references.pmid: 20632860
references.citation: Science. 2012 Dec 7;338(6112):1296-7
references.pmid: 23224541
references.citation: Stem Cells Transl Med. 2012 Jan;1(1):15-7
references.pmid: 23197635
references.citation: Cell Stem Cell. 2012 Jun 14;10(6):678-684
references.pmid: 22704507
references.citation: Stem Cells Transl Med. 2013 Oct;2(10):727-30
references.pmid: 23990574
references.citation: Stem Cells Transl Med. 2012 May;1(5):409-21
references.pmid: 23197820
references.citation: Nat Biotechnol. 2012 Apr 10;30(4):304
references.pmid: 22491271
references.citation: Stem Cell Res Ther. 2013 Aug 14;4(4):98
references.pmid: 23953837
references.citation: J Law Med Ethics. 2010 Summer;38(2):267-76
references.pmid: 20579250
references.citation: Cell Stem Cell. 2013 Oct 3;13(4):382-4
references.pmid: 24094319
references.citation: Regen Med. 2010 Jul;5(4):581-91
references.pmid: 20632861
references.citation: Cytotherapy. 2013 Jan;15(1):9-19
references.pmid: 23260082
references.citation: Cytotherapy. 2012 Oct;14(9):1032-40
references.pmid: 22900960
references.citation: Cell Stem Cell. 2009 Jan 9;4(1):20-6
references.pmid: 19058776